|Basic InformationLookupsLatest News|Ketamine Beneficial for Certain Patients With Mood DisordersPatients Reluctant to Comply With Drug-Only Psychiatric TreatmentPatients Often Reject Drug-Only Psychiatric TreatmentStudy Links Psychiatric Disorders to Stroke RiskAnxiety, Depression May Up Mortality Risk for Some CancersMental Health May Affect Chances Against CancerObamacare Covered More People With Mental Illness, AddictionsMany With Mental Illness Miss Out on HIV TestsPlastic Surgeons Often Miss Patients' Mental DisordersMortality Risk in T2DM Increased With Depression and/or AnxietyMost Smokers With Mental Illness Want to Kick the HabitRate of Psychiatric Drug Use About 16 Percent in U.S. Adults1 in 6 U.S. Adults Takes a Psychiatric Drug: StudyFor People With Mental Health Woes, Pets Can Be InvaluableHealth Tip: Thinking About Psychological Therapy?Heart Rate, BP in Male Teens Tied to Later Risk for Psych DisordersU.S. Psychiatric Patients Face Long Waits in ERsAre Some Blood Pressure Meds Linked to Depression, Bipolar Risk?Study Links Pot Use to Relapse in Psychosis PatientsInternet Addiction May Be Red Flag for Other Mental Health Issues: StudyPsychiatric Patients Face Longer Waits in ERParents' Psychiatric Issues May Adversely Affect Some ChildrenAntipsychotic Meds Pose Little Danger to Fetus, Study FindsInfertility Patients' Mental Health Problems Often UnaddressedStudy of Teen Brains Offers Clues to Timing of Mental IllnessHealth Tip: Take Steps to Stay Mentally HealthyAre 'Workaholics' Prone to OCD, Anxiety?Mentally Ill Still Gain Illegal Possession of Guns, Study ShowsMental Disorders Were Most Costly in U.S. in 2013For New Antipsychotic Users, Dose, Duration Impact MortalityNo Link Between Anti-Smoking Drugs, Mental Health Issues: StudyU.S. Soldier in Custody Following Slaying of 5 Americans in IraqQuestions and AnswersLinksBook Reviews
Ketamine Beneficial for Certain Patients With Mood Disorders
Updated: Mar 8th 2017
WEDNESDAY, March 8, 2017 (HealthDay News) -- Use of ketamine for treatment of mood disorders should include appropriate patient selection and consideration of potential risks of treatment, according to a consensus statement published online March 1 in JAMA Psychiatry.
Gerard Sanacora, M.D., Ph.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues examined data on the use of ketamine for mood disorder treatment.
The researchers note that ketamine may be helpful for some patients with mood disorders. Appropriate patient section should include diagnostic considerations, with the strongest evidence supporting ketamine's benefit in treatment of major depressive disorder without psychotic features, as well as assessment of other medical, psychological, and social factors. Most studies supporting ketamine's benefit assessed efficacy during the first week following a single infusion; emerging studies indicate that repeated dosing may extend the efficacy for at least several weeks. However, the available data are limited and potential risks associated with ketamine should be considered before its use.
"The suggestions provided are intended to facilitate clinical decision making and encourage an evidence-based approach to using ketamine in the treatment of psychiatric disorders considering the limited information that is currently available," the authors write. "This article provides information on potentially important issues related to the off-label treatment approach that should be considered to help ensure patient safety."
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
This article: Copyright © 2017 HealthDay. All rights reserved.